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Abstract
Background: Epidemiological research into the role of traffic pollution on chronic respiratory and
allergic disease has focused primarily on children. Studies in adults, in particular those based on
objective outcomes such as bronchial hyperresponsiveness, skin sensitisation, and lung function, are
limited.
Methods: We have used an existing cohort of 2644 adults aged 18–70 living in Nottingham, UK,
for whom baseline health and demographic data were collected in 1991 and computed two markers
of exposure to traffic: distance between the home and nearest main road and modelled outdoor
nitrogen dioxide (NO2) concentration at the home location. Using multiple regression techniques,
we analysed cross-sectional associations with bronchial hyperresponsiveness, FEV1, spirometry-
defined COPD, skin test positivity, total IgE and questionnaire-reported wheeze, asthma, eczema
and hayfever in 2599 subjects, and longitudinal associations with decline in FEV1 in 1329 subjects
followed-up nine years later in 2000.
Results: There were no significant cross-sectional associations between home proximity to the
roadside or NO2 level on any of the outcomes studied (adjusted OR of bronchial
hyperresponsiveness in relation to living ≤150 m vs >150 m from a road = 0.92, 95% CI 0.68 to
1.24). Furthermore, neither exposure was associated with a significantly greater decline in FEV1
over time (adjusted mean difference in ΔFEV1 for living ≤150 m vs >150 m of a road = 10.03 ml,
95% CI, -33.98 to 54.04).
Conclusion: This study found no evidence to suggest that living in close proximity to traffic is a
major determinant of asthma, allergic disease or COPD in adults.
Background
Many epidemiological studies have examined effects of
exposure to road vehicle traffic on chronic respiratory and
allergic disease in children, but research of the effects in
adults is limited. A handful of studies of adults have
reported that living in close proximity to busy or major
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whilst others have shown no effect on wheeze or asthma
[4-9]. Some of this inconsistency may be due to the use of
self-reported markers of asthma which are potentially
biased, but use of objective markers such as bronchial
hyperresponsiveness (BHR) is rare. Lung function meas-
ures such as one second forced expiratory volume (FEV1)
have been investigated by a few in relation to traffic indi-
ces such as proximity to main roads or modelled traffic-
related pollutants, but again findings in adults are incon-
clusive and evidence of longitudinal effects lacking[10].
Spirometry has also been used to define chronic obstruc-
tive pulmonary disease (COPD) in one study of women
which reported an adverse effect of close residential prox-
imity to a busy road[11]. Investigations of allergy and
atopy in adults have also tended to rely on self-reported
outcomes, and use of objective markers such as skin sen-
sitisation or elevated immunoglobulin E (IgE) rare[6,8].
We have therefore used data from an existing population-
based cohort of adults to compute markers of exposure to
traffic-related pollution and investigate their relation with
objective measures of respiratory and allergic disease,
namely bronchial hyperresponsiveness, FEV1, spirometry-
defined COPD, skin test positivity and total IgE, as well as
questionnaire reported wheeze, asthma, eczema and hay-
fever. In addition to these cross-sectional investigations,
we have also used longitudinal measurements made on
the cohort to examine effects of exposure on change in
FEV1. As the primary traffic related air pollutants are high-
est at the roadside and decline exponentially[12], we have
chosen to use distance between home residence and the
nearest major road as an objective proxy of exposure to
traffic pollution, and to look particularly at dose-response
relations across the first 150 m from the roadside where
most of the decline occurs. We have also used an alterna-
tive marker of exposure based on modelled traffic-related
NO2 at the home location, which may better reflect the
level and type of traffic. Data on number of years resi-
dence in the current home has also enabled us to look
more specifically at long-term effects of exposure by
restricting analyses to long-term residents only.
Methods
Study population
Our study population is a cohort of adults aged 18–70 liv-
ing in the Gedling area of Nottingham City, UK, who were
recruited in 1991 as part of a study of the effect of diet on
chronic lung disease. Gedling is an area of 46 square miles
with an estimated population of 87,000 in 1991 which
covers the north east suburbs of Nottingham and sur-
rounding rural villages. Full details of the study have been
described elsewhere[13]. Briefly, a representative sample
of adults was drawn from the local electoral register and
those of eligible age and residing in the study area were
invited to take part in the study (figure 1). Information on
respiratory and allergic disease symptoms, demographics,
smoking, diet, and numerous other lifestyle factors were
collected using an interview-led questionnaire. FEV1 and
forced vital capacity (FVC) were measured by a study
nurse using a calibrated dry bellows spirometer (Vitalo-
graph, Buckingham, UK) taking the best of three techni-
cally satisfactory manoeuvres with the subject seated; a
methacholine challenge performed to determine BHR
using the technique described by Yan et al[14]; allergen
skin tests to Dermatophagoides pteronyssinus, mixed grass
pollen, cat fur, Aspergillus fumigatus, and Cladosporium her-
barum (Bencard solutions, Brentford, UK) carried out; and
a blood sample taken. In total, 2,644 individuals partici-
pated in the 1991 survey, estimated to be between 48%
and 59% of those eligible [13] (figure 1). The exact
response rate cannot be computed since it was not known
what proportion of the non-responders would have been
eligible for inclusion. In 2000 all surviving individuals
were invited to participate in a follow-up survey (follow-
up rate was 51%) in which these measurements, with the
exception of BHR, were repeated[15]. The surveys were
approved by the Nottingham City Hospital and Notting-
ham University ethics committees.
Computation of exposure variables
We took each subjects home address in 1991 and con-
verted it into a grid reference using information from the
Local Land & Property Gazetteers database held by
Gedling Borough Council. To compute our distance expo-
sure variable, we linked this grid reference to a digitised
road map of Great Britain (Meridian database; Ordnance
Survey, Southampton, UK), which is a geometrically
structured 1:50,000 scale vector database with a coordi-
nate resolution of 1 m. We then calculated the shortest
distance (in metres) between each address location and
the nearest major road, defined as a motorway (freeway),
or 'A' or 'B' class road (principal road as classified by UK
Department for Transport), using Geographical Informa-
tion System (GIS) software (ArcGIS 9.0).
To compute our modelled NO2 variable, we linked each
home location grid reference to a high resolution map of
modelled traffic-related NO2 using ArcGIS. This map was
generated by the dispersion model ADMS Roads (CERC,
Cambridge, UK), which has been widely used to assess the
impact of road traffic on local air quality and extensively
validated against monitored roadside concentrations of
traffic pollutants[16]. Traffic count and composition data
supplied by Nottinghamshire County Council and hourly
sequential meteorological data (including wind direction
and speed) provided by the UK Meteorological Office
were inputted into the model. Background concentration
data were averaged from pollutant data recorded at auto-
mated sites in Nottingham City Centre (urban) and Sut-Page 2 of 11
(page number not for citation purposes)
BMC Pulmonary Medicine 2009, 9:42 http://www.biomedcentral.com/1471-2466/9/42ton Bonnington (rural). Modelled annual mean
concentrations of NO2 were verified through comparison
with observed concentrations (1998–2003) recorded at
10 diffusion tube survey sites (background, intermediate
and roadside) across the study area and overall modelled
values correlated well with observed (r = 0.63). Closer
inspection revealed some underestimation of observed
concentrations at roadside sites close to major road inter-
sections where slow moving or standing traffic is likely
during rush hours. In the absence of more detailed infor-
mation on traffic count, speed and composition the
model is unable to reproduce elevated concentrations at
such localized hot spots. However given the good level of
agreement between modelled and observed concentra-
tions elsewhere (r = 0.88 for the other sites), and the fact
that only a minority of the study population would live
close to such major intersections, the model parameterisa-
tion was deemed satisfactory to invoke deployment across
the entire study area at a spatial resolution of 10 metres.
Flow diagram showing study participationigure 1
Flow diagram showing study participation.Page 3 of 11
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In cross-sectional analyses we assessed the effect of each
exposure variable on each of the following outcome vari-
ables using data from the 1991 baseline survey: self-
reported wheeze in the past year ('Have you had wheezing
or whistling in your chest at any time in the last 12
months?'), diagnosed asthma ('Have you ever had
asthma?' and 'Was this confirmed by a doctor?'), eczema
ever ('Have you ever had eczema or any kind of skin
rash?') and hayfever ever ('Have you ever had hayfever or
other nasal allergies?'); bronchial hyperresponsiveness
(BHR), defined as a methacholine dose provoking a 20%
fall in FEV1 (PD20) of 12.25 mg/ml or less; COPD, defined
as stage I or above using the GOLD (Global Initiative for
Chronic Obstructive Lung Disease) criteria[17] (namely
having an FEV1/FVC less than 70%); allergen skin sensiti-
sation, defined as a response to any of the allergens tested
at least 3 mm greater than the saline control response in
the presence of a positive histamine control; and high
total IgE, defined as a concentration above 100 kU/l. Mul-
tiple logistic regression analyses were carried out to assess
the effect of distance, initially treated as a binary variable
(<= 150 m and >150 m), on each binary outcome,
adjusted for age, sex, smoking status (current, never or ex-
smoker) and quintiles of Carstairs deprivation score
(postcode based index of deprivation based on unem-
ployment, overcrowding, car ownership and occupa-
tion[18]). To investigate dose-response effects, analyses
were then carried out in the subset of respondents living
within 150 m from a road with distance fitted as 50 m
bands (the smallest categorisation possible given the
study sample size). Modelled NO2 was categorised into
quintiles and analysed in a similar way to distance.
The cross-sectional association between each exposure
and FEV1, defined as the best of three satisfactory meas-
urements, was analysed using multiple linear regression
controlling for sex, age, age squared, smoking status, pack-
years of cigarettes smoked, height, Carstairs deprivation
score and age-height interaction. Multiple linear regres-
sion was also used to analyse total IgE as a continuous var-
iable (transformed to achieve a Normal distribution by
adding 1 and taking the logarithm), with adjustment for
age, sex, smoking and Carstairs score.
In longitudinal analyses, we computed changes in
adjusted FEV1 residuals between 1991 and 2000 using the
method described by Carey et al[19]. Briefly, we modelled
predicted FEV1 values for each sex separately in the sub-
group of non-smoking, non-asthmatic, non-wheezing
individuals, with terms for age, height, age squared, and
age-height interaction, and calculated the difference from
predicted as the adjusted FEV1 residuals in 1991 and 2000.
Change in FEV1 residual from 1991 to 2000 was modelled
in relation to the exposure variables using multiple linear
regression, controlling for the effect of smoking and
number of pack-years of cigarettes in 2000 and for Car-
stairs deprivation score as recorded at baseline.
For all analyses we tried adjusting for other potential con-
founders including exposure to passive smoking, older
siblings, indoor heating and cooking appliances, pet own-
ership, vitamin C and E intake, and body mass index. We
also tried controlling for social class based on occupation
as an alternative marker of socio-economic status to Car-
stairs score. Since long-term exposure may be most rele-
vant and inclusion of others could weaken any
associations, we repeated all cross-sectional analyses
restricting to the subgroup of individuals who had lived in
the same address for at least 3 years (long-term residents),
and longitudinal analysis restricting to individuals who
lived in the same address between 1991 and 2000, to
assess whether the magnitude of effect estimates were
altered.
All analyses were performed in STATA 8.2 for Windows
(Stata Corportation, college Station, Texas). The available
sample provided 80% power to detect an odds ratio (OR)
of 1.35 for wheeze (based on an outcome prevalence of
24%) in relation to living within 150 m of a road relative




Of the 2,644 participants in the 1991 baseline survey, we
excluded 44 with invalid or incomplete address informa-
tion and one who had not provided full lung function
data. Cross-sectional analyses were therefore carried out
on 2,599 subjects (98%), of whom 2,351 (90.5%) were
long-term residents (median length of residence 10 years;
interquartile range 5 to 20 years). For the longitudinal
analyses we excluded 14 without valid address informa-
tion and 11 without lung function data, leaving 1,329
individuals (98.2% of participants in the follow-up sur-
vey) for analysis, of whom 997 (75.0%) had resided at the
same address over the period of follow-up. The baseline
characteristics of the study subjects and those lost to fol-
low-up are shown in Table 1. Those followed up in 2000
were generally similar to the 1991 baseline group,
although slightly less likely to be a smoker or in the
youngest age group. Although the characteristics of our
original 7106 adults sampled from the electoral role are
not known, Table 2 shows how the age, sex and social
deprivation (Carstairs) distribution of our participants
compares with that of all Gedling residents in 1991, our
target population, using census data from that year [20]
(Table 2). This shows that those included in our cross-sec-
tional and longitudinal analyses were slightly older than
the target population but similar with respect to genderPage 4 of 11
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of BHR and IgE were carried out on slightly smaller data-
sets due to missing data (figure 1), but demographics were
similar to the complete dataset of 2599 subjects (Table 2).
Just under one quarter of individuals (22.3%, n = 580)
lived within 150 m of a main road and the median level
of modelled NO2 exposure was 34.39 μg/m3 (IQR 34.01
to 35.94). The concentration of modelled NO2 was signif-
icantly related to residential proximity to roads (chi
square p-value < 0.0001) such that those living within 30
m of a road had a median level of 39.79 μg/m3 (IQR 38.13
to 42.34) decreasing to 34.22 μg/m3 (IQR 33.92 to 34.71)
for those living more than 150 m away.
Effect of proximity to a major road on respiratory and 
allergic outcomes
After adjusting for potential risk factors, respondents liv-
ing within 150 m of a major road were not more likely to
have BHR, COPD, positive skin test or high total IgE, or
Table 1: Baseline characteristics of Gedling study participants included in cross-sectional and longitudinal traffic pollution analyses and 
those lost to follow-up
Baseline characteristics Cross-sectional analysis
(N = 2599) Number (%)
Longitudinal analysis
(N = 1329) Number (%)
Lost to follow-up
(N = 1267) Number (%)
Age group
18–29 415 (16.0) 134 (10.1) 281 (22.2)
30–39 553 (21.3) 263 (19.8) 290 (22.9)
40–49 664 (25.6) 369 (27.8) 295 (23.3)
50–59 523 (20.1) 341 (25.7) 181 (14.3)
60–70 444 (17.1) 222 (16.7) 220 (17.4)
Sex
Men 1299 (50.0) 659 (49.6) 639 (50.4)
Women 1300 (50.0) 670 (50.4) 628 (49.6)
Carstairs deprivation quintiles
1st (least deprived) 636 (24.5) 292 (22.0) 282 (22.3)
2nd 457 (17.6) 255 (19.2) 202 (15.9)
3rd 523 (20.1) 307 (23.1) 241 (19.0)
4th 482 (18.6) 220 (16.6) 264 (20.8)
5th (most deprived) 501 (19.3) 255 (19.2) 278 (21.9)
Smoking status
Never 1289 (49.6) 705 (53.1) 583 (46.0)
Ex-smoker 722 (27.8) 387 (29.1) 334 (26.4)
Current smoker 588 (22.6) 237 (17.8) 350 (27.6)
Distance to a main road
<50 m 164 (6.3) 87 (6.6) 77 (6.1)
50 – 100 m 226 (8.7) 112 (8.4) 114 (9.0)
100 – 150 m 190 (7.3) 96 (7.2) 94 (7.4)
> 150 m 2019 (77.7) 1034 (77.8) 982 (77.5)
Modelled quintiles of NO2 (μg/m3)
<33.92 520 (20.0) 267 (20.1) 252 (19.9)
33.92 – 34.23 520 (20.0) 279 (21.0) 240 (18.9)
34.23 – 34.73 520 (20.0) 277 (20.8) 242 (19.1)
34.73 – 36.79 520 (20.0) 248 (18.7) 272 (21.5)
>36.79 519 (20.0) 258 (19.4) 261 (20.6)
Outcomes*
Current wheeze 624 (24.0) 274 (20.6) 347 (27.4)
Diagnosed asthma 231 (8.9) 102 (7.7) 128 (10.1)
COPD** 238 (9.2) 102 (7.7) 135 (10.7)
BHR† 310 (13.0) 147 (11.7) 163 (12.9)
Ever hay fever 662 (25.5) 323 (24.3) 337 (26.6)
Ever eczema 714 (27.5) 365 (27.5) 348 (27.5)
Allergen skin sensitisation 788 (30.3) 406 (30.6) 381 (30.1)
High total IgE‡ 549 (22.3) 258 (20.2) 290 (22.9)
NO2 nitrogen dioxide; COPD chronic obstructive pulmonary disease; BHR bronchial hyper-responsiveness; IgE immunoglobulin E.
* For outcomes, values represent number and % positive where %'s are computed excluding any missing values
**COPD: 7 missing values in cross-sectional study (% = 238/2592) and 1 in longitudinal (% = 102/1328)
† BHR: 216 missing values in cross-sectional study (% = 310/2383) and 74 in longitudinal (% = 147/1255)
‡ IgE: 132 missing values in cross-sectional study (% = 549/2467) and 53 in longitudinal (% = 258/1276)Page 5 of 11
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(Table 3). For wheeze and allergen sensitisation there was
weak evidence of a positive dose-response relation across
the first 150 m from the roadside (p for trend = 0.07 and
0.03 respectively), but not for the other outcomes. There
were no significant associations between proximity and
questionnaire-reported asthma, eczema and hay fever
(adjusted OR (95% CI) 0.95 (0.68 to 1.33), 0.98 (0.78 to
1.22) and 1.00 (0.81 to 1.25) respectively).
Effect of modelled NO2 on respiratory and allergic 
outcomes
There was no evidence that increasing modelled NO2 at
the home was related to an increase in the risk of wheeze,
COPD, BHR, skin sensitisation or high IgE (Table 4). Sim-
ilarly, questionnaire reported asthma, eczema and hayfe-
ver were not significantly related to modelled NO2
(adjusted OR for highest versus lowest quintile 0.96 (0.62
to 1.49), 1.07 (0.81 to 1.41), and 1.02 (0.77 to 1.37),
respectively).
Effect of traffic pollution on lung function measurements
In cross-sectional analyses, those living within 150 m of a
main road were seen to have a similar FEV1 to those living
further away, and amongst those living within 150 m of a
road, there was no trend of reduced FEV1 with increased
proximity (Table 5). Similarly, there was no association
between measured values of lung function and modelled
quintiles of NO2 at home location.
In longitudinal analyses of lung function over the 9 years
of follow-up, decline in FEV1 was similar for those living
within 150 m from the roadside and those living further
away and showed no trend with proximity amongst those
living within 150 m (Table 5). Similarly, there was no sig-
nificant association between modelled NO2 and change in
FEV1 (Table 5).
Further analyses
Further control for other potential confounders, or occu-
pation-based social class as an alternative to Carstairs dep-
rivation score, did not materially alter any of the results,
and restriction of cross-sectional and longitudinal analy-
ses to the sub-group of long-term residents made little dif-
ference to the estimates. When total IgE was analysed as a
continuous variable rather than a binary variable, no sig-
nificant associations were seen with distance (adjusted β
= -0.04, 95% CI -0.11 to 0.03 for <= 150 m relative to
>150 m, p = 0.25) or modelled NO2 (p for trend = 0.69)
(Table 6).
Discussion
In this population-based study of Nottingham adults, we
found no evidence that living close to a main road or in
an area of increased traffic-related pollution was associ-
ated with an increased risk of asthma or COPD. This was
true for both self-reported markers such as disease symp-
toms and diagnosis, and objective markers: BHR and lung
function. Furthermore, in longitudinal analyses, there was
no evidence that increased traffic exposure was associated
with decline in lung function. We found some suggestion
of an adverse effect of home proximity on allergy with a
significant exposure-response across the first 150 m from
roadside for allergic sensitisation, but not for other mark-
ers such as hayfever, eczema or total IgE.
The response rate, both to the original cross-sectional sur-
vey and in the 9 year follow-up of these subjects, was only














 analysis of FEV1
N = 1329
Age group (%)
18–29 24.9 16.0 16.5 15.2 10.1
30–39 21.2 21.3 21.7 21.2 19.8
40–49 22.0 25.6 27.1 26.1 27.8
50–59 16.7 20.1 20.3 20.2 25.7
60–70 15.2 17.1 14.5 17.2 16.7
Sex (%)
Men 49.4 50.0 50.4 50.1 49.6
Women 50.6 50.0 49.6 49.9 50.4
Mean (SD) Carstairs deprivation score -1.29 (2.05) -1.32 (2.17) -1.34 (2.16) -1.32 (2.17) -1.53 (2.15)
BHR bronchial hyper-responsiveness; IgE immunoglobulin E.
*Age and sex %'s based on Gedling 1991 census population aged 18–69 (n = 74899); mean Carstairs based on total Gedling 1991 census population 
(n = 110127)
Census output is Crown copyright and is reproduced with the permission of the Controller of HMSO and the Queen's Printer for Scotland.Page 6 of 11
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response bias. In the 2000 follow-up study, the character-
istics of those who participated were generally similar to
the original 1991 sample, and in particular, participation
rates did not differ according to proximity to a main road.
Whilst the factors associated with participation in the
original 1991 survey are not fully known, proximity to a
main road is not likely to be one of them since respond-
ents and interviewers were unaware of the current hypoth-
esis of investigation. We did find evidence that our study
participants were slightly older than Gedling residents in
the 1991 census[20], but proximity was not associated
with age in our dataset (r = -0.03); socio-economic status
was comparable to the census population and again was
not related to proximity in our dataset (r = -0.03). There-
fore, whilst we cannot completely rule out the possibility
of response bias, it is unlikely to have had a major impact
on our study results.
A strength of this study is that our exposure variables were
computed using GIS techniques from the participant's
exact address rather than postcode used in many previous
studies. We estimated that by using the postcode rather
than the exact address coordinates in the computation of
the binary and the 50 m band distance variables, exposure
status would have misclassified 5% and 33% of respond-
ents respectively. In addition to the commonly used
marker of exposure, residential distance from major
roads, we used a more sophisticated marker of exposure
based on modelled traffic-related NO2 concentrations. As
this incorporated factors such as traffic patterns on the
roads and meteorological influences, it is likely to be a
Table 3: Association between residential proximity to a main road and respiratory and allergic outcomes
Outcomes Number with outcome (%) Adjusted OR*(95% CI) p-value†
Wheezing in last year
≤150 m 129 (22.2) 0.86 (0.68 – 1.08) 0.19
>150 m 495 (24.5) 1
Bands of distance
<50 m 46 (28.1) 1.60 (0.96 – 2.68) 0.07
50 – 100 m 45 (19.9) 1.00 (0.61 – 1.66)
100 – 150 m 38 (20.0) 1
COPD
≤150 m 53 (9.2) 0.97 (0.68 – 1.37) 0.86
>150 m 185 (9.2) 1
Bands of distance
<50 m 16 (9.8) 1.54 (0.69 – 3.45) 0.29
50 – 100 m 24 (10.7) 1.67 (0.79 – 3.49)
100 – 150 m 13 (6.8) 1
BHR
≤150 m 64 (11.9) 0.92 (0.68 – 1.24) 0.57
>150 m 246 (13.3) 1
Bands of distance
<50 m 13 (8.5) 0.54 (0.27 – 1.11) 0.09
50 – 100 m 25 (12.0) 0.80 (0.44 – 1.45)
100 – 150 m 26 (14.7) 1
Allergic sensitisation
≤150 m 163 (28.1) 0.87 (0.70 – 1.07) 0.19
>150 m 625 (31.0) 1
Bands of distance
<50 m 51 (31.1) 1.72 (1.05 – 2.81) 0.03
50 – 100 m 70 (31.0) 1.53 (0.97 – 2.42)
100 – 150 m 42 (22.1) 1
High total IgE
≤150 m 109 (19.7) 0.80 (0.63 – 1.02) 0.07
>150 m 440 (23.0) 1
Bands of distance
<50 m 31 (20.3) 1.21 (0.69 – 2.12) 0.51
50 – 100 m 43 (19.6) 1.01 (0.61 – 1.69)
100 – 150 m 35 (19.3) 1
OR odds ratio; CI confidence interval; COPD chronic obstructive pulmonary disease; BHR bronchial hyper-responsiveness; IgE immunoglobulin E.
* OR adjusted for sex, age group, Carstairs deprivation scores and smoking status
† p-value for trend across bands of distancePage 7 of 11
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we have endeavoured to minimise misclassification by
our choice of exposure variables, they still do not allow for
exposure away from home and the possibility that they
are insufficiently accurate to detect any true adverse effects
that exist can not be ruled out. We also addressed the issue
of our exposure variables being based on current (1991)
home location only, which for those who had moved
house may not be the relevant exposure. However our
subjects had lived in their home for an average of 10 years
and estimates were seen to remain similar when we
restricted analyses to the subgroup of long term residents
only, suggesting we had not missed any effects because of
this issue.
Our findings for asthma fit with a number of previous
studies of adults that also found no adverse effect of living
in close proximity to a major road on self-reported symp-
toms [4-9]. One study that did report an adverse effect
looked at US male veterans and showed that those living
within 50 m of major roads had a increased risk of persist-
ent wheeze, with a significant odds ratio of 1.7 for heavily
trafficked roads (> = 10,000 vehicles a day), but a smaller
effect (OR = 1.3) which reached borderline significance
when all major roads were considered[1]. Two other
recent studies have shown increased risks of wheeze of
borderline significance in relation to increased residential
proximity to surfaced roads in Ethiopia[2] and living
within 20 m of a main street in Switzerland[3]. The Ethi-
opian study differed from most other studies in that it was
conducted in a developing country where background
pollution was thought to be very low, and it may be that
the likelihood of detecting any real effects of home prox-
imity to the roadside are greater in such settings. In our
study, the sampling method and geographical area chosen
are likely to have provided a sample broadly representa-
tive of the general population, but the fact that the
Gedling district is primarily urban means that the major-
ity of the sample live in areas with relatively high back-
ground concentrations of pollutants. Insufficient contrast
in exposure may therefore explain why we were unable to
detect any adverse effects of our localised traffic pollution
Table 4: Association between modelled NO2 level and respiratory and allergic outcomes
Quintiles of modelled NO2 (μg/m3) Number with outcome (%) Adjusted OR* (95% CI) p for trend
Wheezing in last year
<33.92 124 (23.9) 1 0.18
33.92 – 34.23 134 (25.8) 1.03 (0.76 – 1.39)
34.23 – 34.73 122 (23.5) 0.86 (0.63 – 1.16)
34.73 – 36.79 122 (23.5) 0.84 (0.63 – 1.14)
>36.79 122 (23.5) 0.88 (0.66 – 1.19)
COPD
<33.92 46 (8.9) 1 0.95
33.92 – 34.23 50 (9.6) 1.09 (0.68 – 1.73)
34.23 – 34.73 46 (8.9) 0.95 (0.60 – 1.52)
34.73 – 36.79 45 (8.7) 0.91 (0.57 – 1.45)
>36.79 51 (9.8) 1.07 (0.68 – 1.68)
BHR to methacholine
<33.92 59 (12.5) 1 0.29
33.92 – 34.23 69 (14.4) 1.08 (0.73 – 1.60)
34.23 – 34.73 64 (13.3) 0.95 (0.64 – 1.41)
34.73 – 36.79 65 (13.8) 1.03 (0.70 – 1.54)
>36.79 53 (11.1) 0.81 (0.54 – 1.21)
Allergen skin sensitisation
<33.92 162 (31.2) 1 0.68
33.92 – 34.23 157 (30.2) 0.98 (0.74 – 1.30)
34.23 – 34.73 160 (30.8) 1.02 (0.77 – 1.35)
34.73 – 36.79 158 (30.4) 0.97 (0.73 – 1.28)
>36.79 151 (29.1) 0.94 (0.72 – 1.24)
High total IgE
<33.92 114 (23.3) 1 0.22
33.92 – 34.23 117 (23.4) 0.98 (0.72 – 1.33)
34.23 – 34.73 105 (21.6) 0.90 (0.66 – 1.23)
34.73 – 36.79 110 (22.4) 0.90 (0.65 – 1.21)
>36.79 103 (20.7) 0.84 (0.62 – 1.15)
NO2 nitrogen dioxide; OR odds ratio; CI confidence interval; COPD chronic obstructive pulmonary disease; BHR bronchial hyper-responsiveness; 
IgE immunoglobulin E.
* OR adjusted for sex, age group, Carstairs deprivation score and smoking statusPage 8 of 11
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recent study in Rome that also modelled NO2 revealed less
variation in our values (IQR 34.01 to 35.94 μg/m3) than
those that experienced in Rome (IQR 37.3 to 50.3 μg/m3),
although this study also found no positive associations
with asthma either[7]. It is also possible that in some set-
tings, effects of distance on asthma are evident across a
wider range of distances than considered here, as sug-
gested by Gauderman et al who reported a dose-response
effect across the entire range of distance to the nearest free-
way amongst children living in southern California [21].
A number of cross-sectional studies of lung function have,
like ours, found no adverse effect of exposure to traffic on
FEV1 [22-24]. However in a large study of US adults, Kan
et al did find a negative association between traffic density
at the residential location and FEV1, although in women
only[25], and a similar finding was reported in a study of
German woman in relation to living within 100 m of a
major road[11]. In our study, no differential effects by
gender were observed. As with asthma, adverse effects on
lung function have been reported in Californian children
in relation to much larger cut-points in distance (500 m
bands), although again this was for freeways only [26].
Longitudinal studies of decline in FEV1 are more scarce,
but in contrast to our finding of no effect, significant
effects have been reported in relation to traffic-related pol-
lution in Japanese women[9] and Swiss adults[27]. The
Table 5: Effect of proximity and modelled NO2 on cross-sectional FEV1 and longitudinal change in FEV1
Mean (unadjusted) SD β* 95% CI p-value†
Cross-sectional
Distance (N = 2599)
≤150 m 3202.6 898.7 5.73 -42.80 to 54.27 0.82
>150 m 3178.5 924.1 0
Bands of distance (N = 580)
<50 m 3143.4 925.2 38.30 -63.60 to 140.21 0.47
50 – 100 m 3230.8 886.0 -10.65 -104.77 to 83.48
100 – 150 m 3220.1 892.9 0
Quintile of NO2 (N = 2599)
<33.92 3218.0 905.5 0 0.35
33.92 – 34.23 3163.6 940.1 -20.20 -85.00 to 44.59
34.23 – 34.73 3147.0 927.5 -4.72 -69.41 to 59.96
34.73 – 36.79 3213.5 937.9 9.79 -54.69 to 74.27
>36.79 3177.2 880.9 18.12 -45.01 to 81.25
Longitudinal‡ Mean change (unadjusted) SD β** 95% CI p-value†
Distance (N = 1329)
≤150 m -30.6 340.0 10.03 -33.98 to 54.04 0.65
>150 m -36.5 334.0 0
Bands of distance (N = 295)
<50 m -13.8 334.0 46.08 -53.31 to 145.46 0.35
50 – 100 m -19.2 361.6 47.25 -47.43 to 141.93
100 – 150 m -59.1 320.7 0
Quintiles of NO2 (N = 1329)
<33.92 -15.3 333.9 0 0.59
33.92 – 34.23 -24.5 334.3 -18.87 -76.85 to 39.11
34.23 – 34.73 -41.8 329.1 -27.62 -85.68 to 30.45
34.73 – 36.79 -57.6 327.1 -37.52 -96.16 to 21.12
>36.79 -39.0 352.4 -21.58 -79.24 to 36.08
SD standard deviation; β adjusted regression coefficient; CI confidence interval; NO2 nitrogen dioxide.
* β coefficient for cross-sectional FEV1 adjusted for sex, age, age squared, height, age-height interaction, smoking status, cigarette pack-years and 
Carstairs deprivation score, as recorded at baseline
** β coefficient for longitudinal change in FEV1 residuals adjusted for smoking status and cigarette pack years in 2000 and Carstairs deprivation score 
as recorded at baseline
† p-value for trend across quintiles of modelled NO2 and across bands of distance effects
‡ Change in lung function between 1991 and 2000Page 9 of 11
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were unable to analyse in our study as insufficient data
were available for model validation. We also looked at
spirometry-defined COPD using the same definition as
that used previously by Schikowski et al who unlike us
reported a significantly increased odds ratio of 1.79 in
relation to living within 100 m of a busy roads[11]. Stud-
ies that looked at symptoms of COPD such as chronic
cough and dyspnoea have generally found no significant
associations[5,9].
Exposure to traffic pollution could plausibly increase the
risk of sensitisation to allergens as traffic-related pollut-
ants have been shown to enhance immunological
responses to allergens[28]. Our finding of weak evidence
of an effect on allergic sensitisation shows some consist-
ency with that of Wyler and colleagues who reported an
increased risk of skin sensitisation to pollen in relation to
level of traffic at the home location[6]. However, they
found no such effect on sensitisation to indoor allergens
or hay fever[6]. Allergic sensitisation in adults was also
investigated by Heinrich et al using specific IgE to com-
mon allergens and no relation to living near busy roads
was seen[8]. We found no significant effect on hay fever or
eczema in adults, which with one exception[7], is in agree-
ment with others[2,5,6,8]. The lack of consistency of find-
ings across different markers of allergy suggests caution is
needed when interpreting one-off findings of adverse
effects on allergic outcomes.
Conclusion
In conclusion, we found no evidence to suggest that home
proximity to major roads is a major determinant of the
risk of asthma, COPD or allergic disease, or progression of
obstructive lung disease in adults. However, because of
relatively high levels of background pollution in our study
area and possible misclassification of exposure, we cannot
completely rule out an adverse effect, and further study is
needed which incorporate life-time exposure to pollution
in populations with wide variation in exposure.
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<33.92 489 26.8 (9–88) 0 0.92
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